Current evidence on inflammatory biomarkers, including interleukin-6, tumor necrosis factor-alpha, C-reactive protein, the neutrophil-to-lymphocyte ratio, and serum albumin are synthesized to clarify their clinical utility and to support efforts toward standardized assessment, early recognition, and improved monitoring...
Shawna Landon, Jaclyn M. Hall, Saunjoo L. Yoon· Current Oncology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.